Prokidney Corp. financial data

Symbol
PROK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2000 Frontis Plaza Blvd., Suite 250, Winston Salem, North Carolina
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
Social Capital Suvretta Holdings Corp. III (to 7/11/2022)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.77 K % -53.1%
Debt-to-equity -2.27 % -57.4%
Return On Equity 3.06 %
Return On Assets -8.09 %

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 108 M USD +36.8%
General and Administrative Expense 42.4 M USD -12.1%
Operating Income (Loss) -151 M USD -18.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -129 M USD -11%
Income Tax Expense (Benefit) 4.77 M USD +293%
Net Income (Loss) Attributable to Parent -35.3 M USD +1.79%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.4 M USD -68.9%
Other Assets, Current 0 USD -100%
Assets, Current 340 M USD -29.2%
Property, Plant and Equipment, Net 41.9 M USD +255%
Operating Lease, Right-of-Use Asset 5.53 M USD +93.8%
Assets 388 M USD -21.7%
Accounts Payable, Current 3.38 M USD -11.2%
Accrued Liabilities, Current 13.3 M USD +93.5%
Liabilities, Current 19.3 M USD +71.1%
Accrued Income Taxes, Noncurrent 568 K USD +33.3%
Operating Lease, Liability, Noncurrent 4.77 M USD +105%
Liabilities 24.7 M USD +74.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -44 K USD -132%
Retained Earnings (Accumulated Deficit) -1.15 B USD +29.2%
Stockholders' Equity Attributable to Parent -1.1 B USD +31.6%
Liabilities and Equity 388 M USD -21.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -34.6 M USD -33.3%
Net Cash Provided by (Used in) Investing Activities 58.4 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23.7 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.4 M USD -68.9%
Deferred Tax Assets, Valuation Allowance 12.9 M USD +287%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 14.4 M USD +182%
Operating Lease, Liability 5.81 M USD +100%
Depreciation 3.16 M USD +27.4%
Payments to Acquire Property, Plant, and Equipment 960 K USD -2.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.67 M USD +0.19%
Lessee, Operating Lease, Liability, to be Paid 7.42 M USD +109%
Operating Lease, Liability, Current 1.04 M USD +81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.74 M USD +105%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.65 M USD +96.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +10.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.61 M USD +147%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.44 M USD +86%
Deferred Tax Assets, Operating Loss Carryforwards 294 K USD
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.06 M USD +133%
Operating Lease, Payments 279 K USD +37.4%
Additional Paid in Capital 53.1 M USD +144%
Amortization of Intangible Assets 213 K USD -0.93%
Depreciation, Depletion and Amortization 1.1 M USD +32.5%
Deferred Tax Assets, Net of Valuation Allowance 1.49 M USD -15.1%
Share-based Payment Arrangement, Expense 25.5 M USD -26.7%
Interest Expense 11 K USD -33.3%